Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;52:666-671
Published online before print August 18, 2008, doi: 10.1161/HYPERTENSIONAHA.108.114058
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
52/4/666    most recent
HYPERTENSIONAHA.108.114058v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sampson, A. K.
Right arrow Articles by Denton, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sampson, A. K.
Right arrow Articles by Denton, K. M.
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow ACE/Angiotension receptors
Right arrow Gene expression
Right arrow Hypertension - basic studies
Right arrow Physiological and pathological control of gene expression
Right arrowRelated Article

(Hypertension. 2008;52:666.)
© 2008 American Heart Association, Inc.


Original Articles

Enhanced Angiotensin II Type 2 Receptor Mechanisms Mediate Decreases in Arterial Pressure Attributable to Chronic Low-Dose Angiotensin II in Female Rats

Amanda K. Sampson; Karen M. Moritz; Emma S. Jones; Rebecca L. Flower; Robert E. Widdop; Kate M. Denton

From the Departments of Physiology (A.K.S., R.L.F., K.M.D.) and Pharmacology (E.S.J., R.E.W.), Monash University, Clayton, Victoria; and the School of Biomedical Sciences (K.M.M.), University of Queensland, Queensland, Australia.

Correspondence to Kate M. Denton, Department of Physiology, Building 13F, Monash University, Victoria, Australia 3800. E-mail kate.denton{at}med.monash.edu.au

The renin-angiotensin system is a far more complex enzymatic cascade than realized previously. Mounting evidence suggests sex-specific differences in the regulation of the renin-angiotensin system and arterial pressure. We examined the hemodynamic responses, angiotensin II receptor subtypes, and angiotensin-converting enzyme 2 gene expression levels after graded doses of angiotensin II in males and females. Mean arterial pressure was measured via telemetry in male and female rats in response to a 2-week infusion of vehicle, low-dose (50 ng/kg per minute SC) or high-dose (400 ng/kg per minute SC) angiotensin II. The effect of concurrent infusion of the angiotensin II type 2 receptor (AT2R) blocker (PD123319) was also examined. The arterial pressure response to high-dose angiotensin II was attenuated in females compared with males (24±8 mm Hg versus 42±5 mm Hg; P for the interaction between sex and treatment <0.002). Remarkably, low-dose angiotensin II decreased arterial pressure (11±4 mm Hg; P for the interaction between sex and treatment <0.02) at a dose that did not have an effect in males. This decrease in arterial pressure in females was abolished by AT2R blockade. Renal AT2R, angiotensin-converting enzyme 2, and left ventricular AT2R mRNA gene expressions were markedly greater in females than in males with a renal angiotensin II type 1a receptor:AT2R ratio of {approx}1 in females. Angiotensin II infusion did not affect renal AT2R mRNA expression but resulted in significantly less left ventricular mRNA expression. Renal angiotensin-converting enzyme 2 mRNA expression levels were greater in females than in males treated with high-dose angiotensin II ({approx}2.5 fold; P for the interaction between sex and treatment <0.05). In females, enhancement of the vasodilatory arm of the renin-angiotensin system, in particular, AT2R and angiotensin-converting enzyme 2 mRNA expression, may contribute to the sex-specific differences in response to renin-angiotensin system activation.


Key Words: basic science • gender differences • gene expression/regulation • hypertension • angiotensin receptors


Related Article:

Why Can’t a Woman Be More Like a Man?: Is the Angiotensin Type 2 Receptor to Blame or to Thank?
Kathryn Sandberg and Hong Ji
Hypertension 2008 52: 615-617. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
HypertensionHome page
D. J. Campbell
Can the Study of Female Rats Help Our Understanding of Women?
Hypertension, December 1, 2008; 52(6): e142 - e142.
[Full Text] [PDF]


Home page
HypertensionHome page
A. K. Sampson, K. M. Moritz, E. S. Jones, R. E. Widdop, and K. M. Denton
Response to Can the Study of Female Rats Help Our Understanding of Women?
Hypertension, December 1, 2008; 52(6): e143 - e143.
[Full Text] [PDF]


Home page
HypertensionHome page
K. Sandberg
Response to Can the Study of Female Rats Help Our Understanding of Women?
Hypertension, December 1, 2008; 52(6): e144 - e144.
[Full Text] [PDF]


Home page
HypertensionHome page
K. Sandberg and H. Ji
Why Can't a Woman Be More Like a Man?: Is the Angiotensin Type 2 Receptor to Blame or to Thank?
Hypertension, October 1, 2008; 52(4): 615 - 617.
[Full Text] [PDF]